Novo Nordisk (NVO), the maker of the popular GLP-1 medications Wegovy and Ozempic, said potential tariffs on Europe imposed by U.S. President Donald Trump could affect its business.

President Donald Trump is facing pressure from U.S. hospitals and generic drugmakers to exempt medical goods from his new tariffs on Chinese imports, as they join big pharma lobbyists who have said such trade barriers will cause shortages of medicines and higher prices in the United States.

Trump initiated the sweeping tariffs to “hold Mexico, Canada, and China accountable to their promises of halting illegal immigration and stopping poisonous fentanyl and other dr

A trade war with China could shock fragile global health care supply chains, driving up the cost of medical supplies, intensifying shortages of common drugs and limiting U.S. medical device makers' ability to import critical parts.